Abstract

BackgroundResearch is needed to examine differences in multiple sclerosis (MS) prevalence by race-ethnicity. The goal of this study was to quantify MS prevalence in a health care system in Northern California and examine differences in prevalence and phenotype by race-ethnicity.MethodsWe conducted a retrospective, observational cohort study of adults (2010–2016). MS prevalence estimates were standardised to distributions of gender and race-ethnicity for the underlying geographic region and stratified by gender and race-ethnicity with age adjustment. We performed a chart review of a racial-ethnic stratified sample of patients to examine disease phenotypes.Results1,058,102 patients were identified, of which 3286 had MS. The overall direct-standardised prevalence was 288.0 cases per 100,000 population (95% confidence interval: 276.3–299.8). Age-adjusted prevalence ranged from 677.0 per 100,000 among non-Hispanic black women to 49.7 per 100,000 among non-Hispanic Asian men. Non-Hispanic blacks compared with other groups more often had primary-progressive (10.0% vs. 0.0–4.0%) or progressive-relapsing MS (6.0% vs. 0.0–2.0%).ConclusionsIn this Northern Californian Cohort, between 2010 and 2016 the direct-standardised MS prevalence was estimated at 288.0 per 100,000 population, and increased over time. Non-Hispanic blacks, especially women, were disproportionately affected and had less common, earlier progressive MS phenotypes.

Highlights

  • Research is needed to examine differences in multiple sclerosis (MS) prevalence by race-ethnicity

  • The burden of MS has been shown to differ by race and ethnicity, with persons of African descent generally having a lower risk of MS than Caucasians [6]; this evidence is mostly based on ecological studies

  • In a more recent study from Southern California, MS incidence was found to be higher among African Americans than non-Hispanic whites (NHWs) between 2008 and 2010 (10.2 vs. 6.9 cases per 100,000 person-years, respectively), among African American women (14.7 per 100,000 person-years) [7]

Read more

Summary

Introduction

Research is needed to examine differences in multiple sclerosis (MS) prevalence by race-ethnicity. The goal of this study was to quantify MS prevalence in a health care system in Northern California and examine differences in prevalence and phenotype by race-ethnicity. The burden of MS has been shown to differ by race and ethnicity, with persons of African descent generally having a lower risk of MS than Caucasians [6]; this evidence is mostly based on ecological studies. Prevalence and Romanelli et al BMC Neurology (2020) 20:163 incidence of MS consistently have been shown to be lower among Hispanics and Asians relative to Caucasians [6,7,8]. More studies are needed to understand differences in MS prevalence between diverse racial-ethnic groups residing in the same geographic region

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call